Nitra's Impressive Funding Round
Nitra, an AI-native platform for healthcare practices, has raised $187 million in financing across Series A, Series B rounds, venture debt, and a warehouse facility, bringing its total capital raised to $205 million. This substantial funding round comes after the company experienced a remarkable growth of 740% in 2025, reaching over $33 million in annualized revenues (ARR).
Key Investors and Board Expansion
The financing includes notable investors such as Actions Capital, AppWorks, Comma Capital, and others, with Dr. Richard Park, founder and former CEO of CityMD, joining Nitra’s Board of Directors. This strategic move is expected to add significant operational healthcare experience as the company scales.
Nitra's Platform and Market Impact
Nitra's all-in-one platform, launched in 2024, embeds AI agents into the operational backbone of medical practices, aiming to reduce administrative overload for physicians. The platform includes financial automation, commerce and inventory management, and patient management features. In 2025, Nitra processed over $1 billion in annualized volumes and is on track to exceed $4 billion in 2026.
Growth and Future Plans
With the new funding, Nitra plans to accelerate AI development, expand its engineering team, and scale its operating system across thousands of healthcare practices nationwide. The company also anticipates its headcount to grow from 50 to over 200 by the end of 2026 and aims to launch additional AI modules.
Market Context and Nitra's Role
The U.S. healthcare industry, valued at nearly $5.9 trillion, sees an estimated 25% of spending going toward administrative costs. Nitra addresses this by unifying fragmented systems into a single AI-native operating system, enhancing efficiency in operations for healthcare practices.
“We’re on a mission to serve the people that serve our communities and help doctors save time and money,” said Tim Hwang, CEO of Nitra.